Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 501–600 of 805
Risom, S. S., Amdi, K. V., Wahlström, M., Rasmussen, T. B., Sharma, S. K., Kabir, Z. N., & Konradsen, H. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04846-6 · Cited by 1
Shi, S., Chen, W., Deng, L., Chen, K., & Liao, Y. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf036 · Cited by 1
Cardiovascular safety and efficacy of intensive blood pressure control: how low should we go?
Karakasis, P., Patoulias, D., Antoniadis, A. P., Fragakis, N., & Gómez‐Huelgas, R. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.04.006 · Cited by 1
Hypertension Control: The Effect of Dietary Patterns and Lifestyle
Yonis, O. B. (2025) · Physiology · doi:10.5772/intechopen.1010551 · Cited by 3
Leow, A. S., Sule, A. A., Tay, J. C., Teong, H. H., Moy, W. L., Handa, P. K., Wu, Y. T., Chadachan, V. M., Oh, V. M. S., Sia, C., et al. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-094 · Cited by 1
“[19,20]”
Gilyarevskiy, S. R., Shchedrina, A. Y., Eruslanova, K. A., Kozhevnikova, M. V., Вячеславовна, Л. А., Gotina, A. D., Анатольевна, Ж. Е., Дмитриевич, З. В., Kotovskaya, Y. V., Belenkov, Y. N., et al. (2025) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2025-2401 · Cited by 1
Briones‐Valdivieso, C., Núñez, C. S., Celis, A., Araneda‐Flores, J., Cristi‐Montero, C., O’Donovan, G., Celis-Morales, C. A., Deo, S. V., & Petermann-Rocha, F. E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325519 · Cited by 1
“In this context, lower blood pressure goals have been proposed to decrease the incidence of cardiovascular events [20,21] with no significant differences in adverse events, such as symptomatic hypotension, injurious falls, and syncope, among old patients [21].”
Li, X., Zhao, W., Li, Z., Sun, T., Zhu, F., & Wang, D. (2025) · American Journal of Nephrology · doi:10.1159/000548772 · Cited by 2
Ikigai in aging hearts: Japan’s approach to cardiovascular care
Nakamaru, R., Hara, A., Yamada, Y., Sawano, M., & Yamamoto, K. I. (2025) · Hypertension Research · doi:10.1038/s41440-025-02396-5 · Cited by 1
Ishikawa, S.-I., Hayashi, Y., Abe, T., & Tanaka, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328142 · Cited by 1
Blood Pressure Targets in the 2025 AHA/ACC/Multisociety High Blood Pressure Guideline
Wang, J.-G. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.002 · Cited by 1
Key insights of the Clinical Practice Guidelines for the Management of Hypertension in China
Wang, Y., Deng, Q., & Cai, J. (2025) · Cardiac Research · doi:10.1097/re9.0000000000000002 · Cited by 2
Self-citationCase-Based Applications of the 2025 AHA/ACC/Multispecialty High Blood Pressure Guideline
Cameron, N. A., Jones, D. W., Khan, S. S., & Lloyd‐Jones, D. M. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25913 · Cited by 1
Lee, V., Siami, H., Peschard, V.-G., Malekinejad, M., Huang, E., Tahir, P., & Hsu, C. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101193 · Cited by 2
Pros and cons of lower blood pressure targets in chronic kidney disease
Hernandez, M. R. F., & Chang, T. I. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001153 · Cited by 1
Troy, A. L., Anderson, T. S., Razavi, A. C., Schott, S. L., Spitz, J. A., & Blumenthal, R. S. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101410 · Cited by 1
“In the STEP trial of intensive BP lowering in Chinese adults age 60-80, there was no difference in adverse events between the two arms, aside from hypotension which was more common in the intensive arm [39].”
Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease
Zhang, T., Zhou, Z., Li, Q., Cai, X. T., Lin, L., Peng, H., Li, M., Wang, C., & Jiang, X. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.54035 · Cited by 2
Nocturnal Hypertension and Prognosis in Patients of Very Advanced Age
Fujiwara, T., Hoshide, S., & Kario, K. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.25199 · Cited by 3
Self-citationEbrahimi, N., Masrouri, S., Fardoost, S., Azizi, F., & Hadaegh, F. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-025-01107-4 · Cited by 1
Abudukeremu, A., Luo, Q., Wang, M., Zhu, Q., Cai, X., Abuduheilili, Z., Tulake, S., Dang, Y., & Li, N. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.005 · Cited by 1
Николаевна, А. О., Osipova, I. V., & Викторовна, П. Н. (2026) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2026-16-1-5-11 · Cited by 1
Lyu, Y., Zhang, J., Liu, Y., Liu, Y., Bian, W., Chen, K., Jiang, Z., Chen, T., & Li, C. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012643 · Cited by 2
Liu, Y., Lyu, Y., Liu, Y., Zhang, J., Song, Z., Chen, K., Jiang, Z., Yan, H., Chen, T., & Li, C. (2026) · Kidney International · doi:10.1016/j.kint.2026.02.032 · Cited by 1
McCormick, J. P., Bacquer, D. D., Jennings, C. S., Kotseva, K., Backer, G. D., Erlund, I., Ganly, S., Vihervaara, T., Lip, G. Y. H., Ray, K. K., et al. (2026) · Heart · doi:10.1136/heartjnl-2025-327413 · Cited by 1
Self-citationConsolim‐Colombo, F. M., Précoma, D. B., Camazzola, F. E., ABIB, E., Franco, D. R., Magalhães, L. B. N. C., Spinelli, A. C. D. S., Gemelli, J. R., Borges, J. L. C., Montenegro, R. M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083022 · Cited by 1
Bian, W., Wang, F., Wang, H., Shao, Q., Li, S., Zhang, S. Y., & Yan, X. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70263 · Cited by 2
Self-citationZhao, X., Liu, D., Gao, K., & Liu, B. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104775 · Cited by 1
Orthostatic blood pressure transitions: Association with symptoms and frailty
Filho, E. C. D. A., Cesena, F. Y., Blaas, B. N., de Faria, M. M. P., de Biaso, S. T., Yoshioka, C. Y., Pires, M. S. C., Britto, R. M. D. C., de Sousa, M. G., Consolim‐Colombo, F. M., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004325 · Cited by 2
Hypertension and left ventricular geometry: Diagnosis, prognosis, and management
Mutai, S., Kadambi, N., Moazzam, M., & Oktay, A. A. (2026) · EXCLI journal · doi:10.17179/excli2026-9416 · Cited by 1
The optimal blood pressure target in old and very old patients with hypertension
Zhang, R. G., Lam, I. C. H., Liu, X., Sun, F., Zhan, S., Yiu, K. H., Chui, C. S. L., Chan, E. W., Wong, I. C. K., Lam, C. L. K., et al. (2026) · Age and Ageing · doi:10.1093/ageing/afag167 · Cited by 1
Barac, A., Guha, A., Fleming, T. R., Bonaca, M. P., Thavendiranathan, P., Deswal, A. M., Amiri‐Kordestani, L., Bhatnagar, V., Córdoba, R., Hurvitz, S. A., et al. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-25-01647 · Cited by 2
Choker, A. H. (2026) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70142 · Cited by 1
PREVENT Equations: Implications for Stroke Prevention
Ahmed, T., Mathew, R. O., Elkind, M. S. V., & Kulshreshtha, A. (2026) · Stroke · doi:10.1161/strokeaha.126.053362 · Cited by 1
Romero-Vera, L., la Fuente, J. L.-D., Guede-Rojas, F., Carvajal-Parodi, C., Araya-Sierralta, S., Pérez-Contreras, J., Ulloa-Díaz, D., & Perea, Á. R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145531 · Cited by 1
Santo, K., Martins, E. B., Silva, G. S., Guimaraes, P. O., Tavares, C. A. M., de Andrade, J. B. C., Monfardini, F., Nieri, J., Assis, S. R. L., Felício, J. S., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107545 · Cited by 1
Wang, M., Qian, F., Chu, X., Li, A. L., & Li, H. (2026) · QJM · doi:10.1093/qjmed/hcag200 · Cited by 1
Cardiovascular risk management in the elderly: a dilemma in daily clinical practice
Dacquino, G. M., Galati, G., Genovese, L., Bravo, F. F., Bernardi, M., Spadafora, L., & Pedretti, R. F. E. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag316 · Cited by 1
Zhao, J., Dong, X., Song, Q., & Cai, J. (2026) · Hypertension Research · doi:10.1038/s41440-026-02754-x · Cited by 1
Self-citationSilva, G. S., Machline-Carrion, M. J., Santo, K., de Andrade, J. B. C., Martins, E. B., Guimarães, P. O., Monfardini, F., Nieri, J., Assis, S. R. L., Martins, S. C. O., et al. (2026) · European Stroke Journal · doi:10.1093/esj/aakag118 · Cited by 1
Park, S., Kim, S., Kim, K., & Lee, H. (2026) · International Journal of Heart Failure · doi:10.36628/ijhf.2026.0059 · Cited by 1
Chang, T. I., Cluett, J., Cohen, D. L., Drawz, P. E., Hudson, J. Q., Kramer, H., Rahman, M., & Awdishu, L. (2026) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2026.07.006 · Cited by 1
Hypertension management in the COVID-19 era. Getaway from pandemic snares
Wolf, J., & Narkiewicz, K. (2021) · Arterial Hypertension · doi:10.5603/ah.a2021.0024 · Cited by 1
Another STEP towards tighter control of blood pressure in the elderly
Volpe, M., & Patrono, C. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab728 · Cited by 1
Tantisattamo, E., Hamiduzzaman, A., Sohn, P., Ahdoot, R. S., & Hanna, R. M. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000759 · Cited by 1
Blood Pressure Management in the Patient with Chronic Kidney Disease
Muntner, P., Cushman, W. C., & Lerma, E. V. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13040921 · Cited by 1
Bluthochdrucktherapie bei Patienten mit CKD
Hoyer, J. D., Ostermaier, C., & Mann, J. F. E. (2022) · Der Nephrologe · doi:10.1007/s11560-021-00545-8 · Cited by 1
Improving outcomes for older hypertensive patients: is more intensive treatment better?
Deng, Y., Liu, Y., Li, Y., Bai, J., & Cai, J. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2058491 · Cited by 1
Self-citationLiew, C. H., & McEvoy, J. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00031-5 · Cited by 3
Les meilleures études de 2021 adéquates pour les soins de première ligne: De l’équipe du groupe PEER
Moe, S. S., Thomas, B., Kolber, M. R., Korownyk, C. S., Lindblad, A. J., Dugré, N., Turgeon, R. D., Braschi, É., & Allan, G. M. (2022) · Canadian Family Physician · doi:10.46747/cfp.6805334 · Cited by 1
Importance of Vascular Function in Patients with Heart Failure with Preserved Ejection Fraction
Kiuchi, S., & Ikeda, T. (2022) · Medical Research Archives · doi:10.18103/mra.v10i5.2791 · Cited by 1
The cutoff BP values for hypertension should not be lowered in China
Guo, R., & Guo, Y.-F. (2022) · Hypertension Research · doi:10.1038/s41440-022-00969-2 · Cited by 1
O’Donoghue, P., O’Halloran, A. M., Kenny, R. A., & Romero‐Ortuño, R. (2022) · HRB Open Research · doi:10.12688/hrbopenres.13522.1 · Cited by 1
Wang, T. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002109 · Cited by 2
Self-citationConsiderations for Optimal Blood Pressure Target of Hypertension
Ling, Q., & Cai, J. (2022) · Cardiology Discovery · doi:10.1097/cd9.0000000000000056 · Cited by 1
Self-citationBalletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1908-0612 · Cited by 1
Yang, T.-L., Zhong, H., Wang, W., & Wang, J. (2022) · Chinese Medical Sciences Journal · doi:10.24920/004167 · Cited by 1
Armas-Padrón, A. M., Sicilia-Sosvilla, M., Esteban, P. R., Torres, A., & Hernández, D. (2022) · Nefrología · doi:10.1016/j.nefro.2022.12.002 · Cited by 3
Hypotension in Older Treated Hypertensive Patients. Epidemiological Burden and Detection Efficiency
Banegas, J. R. (2022) · ANALES RANM · doi:10.32440/ar.2022.139.02.rev02 · Cited by 2
Best Practices in Medical Management of Chronic Hypertension
Boyle, R., & Remer, L. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.10.014 · Cited by 1
Deprescribing Antihypertensive Medications in Older People: A Narrative Review, Part 1
Russell, P. T., Thompson, C. H., & Mangoni, A. A. (2023) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2023.76 · Cited by 2
How Low Should We Go? Managing Hypertension in Older People
Pogge, E. K. (2023) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2023.74 · Cited by 1
Saely, C. H., Schernthaner, G.-H., Brix, J. M., Klauser‐Braun, R., Zitt, E., Drexel, H., & Schernthaner, G. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02189-1 · Cited by 1
Won, K., Choi, S., Chun, E. J., Park, S. H., Sung, J., Jung, H. O., & Chang, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113770 · Cited by 1
Review of the top 5 cardiology studies of 2021-22
Barry, A. R., Boswell, R., Babadagli, H. E., Chen, J. W., Pollmann, D. M., & Zhou, J. S. (2023) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635231176267 · Cited by 1
Shi, M., Liu, Y., Wang, S., Wang, R., Yang, P., Peng, Y., Peng, H. Y., Wang, A., Xu, T., Chen, J., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003523 · Cited by 1
Balletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2076-0248 · Cited by 1
Kim, J. H., Joo, H. J., Chung, S. H., Yum, Y., Kim, Y. H., & Kim, E. J. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003544 · Cited by 1
Blood pressure control in patients aged above and below 75 years
Jung, H. H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297103 · Cited by 1
Intensive blood pressure control does not lower risk of cardiac conduction system diseases
(2024) · Nature Aging · doi:10.1038/s43587-024-00605-3 · Cited by 1
Gilarevsky, S. R. (2024) · Kardiologiia · doi:10.18087/cardio.2024.4.n2646 · Cited by 1
Омариевна, У. Ф., Demidova, T. Y., & Panteleeva, S. V. (2024) · FOCUS Endocrinology · doi:10.15829/2713-0177-2024-5-1-06 · Cited by 1
Balletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0680 · Cited by 1
How to reduce the risk of ischemic stroke? Overview of recommendations and their effectiveness
Bondos, B., Niewiadomska, J., Stępień, A., Paluch, A., Skrzypek, J., Niekra, A., Fussek, Ł., Kochan, R., Wieczorek, E., & Lee, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.75.56337 · Cited by 1
Lee, J. K., Nicholas, J. S., Albadawi, A., & Insel, K. C. (2025) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2025.1476998 · Cited by 1
Si, Y., Lu, B., Ma, L., Zheng, J., & Wang, W. E. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105828 · Cited by 1
Walker, J. M., Won, D., Patel, R. S., Ning, H., & Lloyd‐Jones, D. M. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039659 · Cited by 1
Blood Pressure and Cardiovascular Outcomes in Adults With Diabetes and Chronic Kidney Disease
Lee, H., Jhee, J. H., Kim, E., Son, D., Kim, H. C., Shimbo, D., & Lee, H. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042966 · Cited by 1
The time to benefit from intensive hypertensive control is now
Supiano, M. A. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17729 · Cited by 1
Optimizing Blood Pressure Components for a Healthy Brain
Fernández‐Jiménez, R., & Real, C. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.046 · Cited by 1
Du, C. X., Huang, C., Lu, Y., Spatz, E. S., Lipska, K. J., & Krumholz, H. M. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.07.023 · Cited by 1
Heart failure with preserved ejection fraction in China: an urgent need for improving the management
Zhang, Y., Feng, J., & Zhang, J. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2718 · Cited by 1
Economic evaluation of a new blood pressure target for hypertensive patients in Taiwan
Minegishi, S., & Nishiyama, A. (2023) · Hypertension Research · doi:10.1038/s41440-022-01125-6 · Cited by 1
Saladini, F., & Palatini, P. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad150 · Cited by 1
Deng, Y., Zhang, J., Chen, Z., Bai, J., Yang, X., Yu, C., Yu, J., & Cai, J. (2024) · medRxiv · doi:10.1101/2024.03.04.24303756 · Cited by 1
Self-citationHighlights from the New European Society of Hypertension Guidelines Document
Grassi, G. M. (2024) · Current Hypertension Reviews · doi:10.2174/0115734021309169240508110407 · Cited by 1
Automated Office BP Monitor Measurements: What Is The Secret Sauce?
Green, B. B. (2024) · American Journal of Hypertension · doi:10.1093/ajh/hpae148 · Cited by 1
Curneen, J. M. G., & McEvoy, J. W. (2025) · Heart · doi:10.1136/heartjnl-2025-326336 · Cited by 1
Hypertension in elderly patients: The urgent unmet needs and challenge
Yeh, C., Lin, Y.-H., & Tsai, C. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.07.006 · Cited by 1
Achieving Intensive Systolic Blood Pressure Control
Muntner, P., & Bowling, C. B. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.067 · Cited by 1
Definition and classification of office and out-of-office blood pressure across recent guidelines
Asayama, K., Kikuya, M., & Ohkubo, T. (2026) · Hypertension Research · doi:10.1038/s41440-025-02543-y · Cited by 1
When “Intensive” Becomes Standard
Krumholz, H. M. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.03.074 · Cited by 1
Never has systolic hypertension in the elderly been so topical
Jolobe, O. M. P. (2021) · QJM · doi:10.1093/qjmed/hcab261
STEP Towards Better Blood Pressure Control: The Prime Time for a Universal Target of < 130/80 mmHg.
Wang, T. (2021) · PubMed · doi:10.6515/acs.202111_37(6).20211103a
Self-citationYu, Y., & Staessen, J. A. (2021) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2021.200122
(2021) · The Nurse Practitioner · doi:10.1097/01.npr.0000803000.35537.f8
Thompson, B., & McEvoy, J. W. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.2013814 · Cited by 1
Lanthier, L., Lauzon, D., Plourde, M.-É., & Cauchon, M. (2022) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.12.002
Lp (a): An Independent Predictive Marker In DiseasesPreprint
Wu, M., Liu, W., & Xiang, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1290162/v1
Self-citationOtt, C., & Schmieder, R. E. (2022) · Kidney International · doi:10.1016/j.kint.2022.01.026
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.